Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative approach

Brain, Behavior, and Immunity

Volumn 24, Issue 8, 2010, Pages 1231-1240

  Lutgendorf, Susan K ^a,b,c   Mullen Houser, Elizabeth ^a   Russell, Daniel ^d   DeGeest, Koen ^b   Jacobson, Geraldine ^b   Hart, Laura ^e   Bender, David ^b   Anderson, Barrie ^b   Buekers, Thomas E ^b   Goodheart, Michael J ^b   Antoni, Michael H ^f   Sood, Anil K ^g   Lubaroff, David M ^b,c,e  

^a E11 SSH   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d IOWA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cervical cancer; Complementary and alternative medicine; Healing Touch; NK cell cytotoxicity; Psychoneuroimmunology; Relaxation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DEPRESSION; ERYTHROCYTE COUNT; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALING TOUCH; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; THERAPY DELAY; UTERINE CERVIX CANCER;

ADULT; AFFECT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; COMPLEMENTARY THERAPIES; ERYTHROCYTE COUNT; FEMALE; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY; RELAXATION; RELAXATION THERAPY; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; THERAPEUTIC TOUCH; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77957243585     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.06.014     Document Type: Article

References (65)

1. Andersen B., Yang H., Farrar W. Psychologic intervention improves survival for breast cancer patients. Cancer 2008, 113:3450-3458.
2. Antoni M.H. Stress management intervention for women with breast cancer 2003, American Psychological Association, Washington, D.C.
3. Antoni M.H., Lechner S., Diaz A., Vargas S., Holley H., Phillips K., McGregor B., Carver C.S., Blomberg B. Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain. Behav. Immun. 2009, 23:580-591.
4. Antoni M.H., Pereira D.B., Marion I., Ennis N., Andrasik M.P., Rose R., McCalla J., Simon T., Fletcher M.A., Lucci J., Efantis-Potter J., O'Sullivan M.J. Stress management effects on perceived stress and cervical neoplasia in low-income HIV-infected women. J. Psychosom. Res. 2008, 65:389-401.
5. Arreygue-Garcia N.A., Daneri-Navarro A., del Toro-Arreola A., Cid-Arregui A., Gonzalez-Ramella O., Jave-Suarez L.F., Aguilar-Lemarroy A., Troyo-Sanroman R., Bravo-Cuellar A., Delgado-Rizo V., Garcia-Iglesias T., Hernandez-Flores G., Del Toro-Arreola S. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer 2008, 8:16-26.
6. Astin J., Harkness E., Ernst E. The efficacy of " Distant Healing": a systematic review of randomized trials. Ann. Int. Med. 2000, 132:903-910.
7. Balaram P., Pillai R., Padmanabhan T., Abraham T., Hareendran N., Nair M. Immune function in malignant cervical neoplasia: a multiparameter analysis. Gyn. Oncol. 1988, 31:409-423.
8. Beano A., Signorino E., Evangelista A., Brusa D., Mistrangelo M., Polimeni M.A., Spadi R., Donadio M., Ciuffreda L., Matera L. Correlation between NK function and response to trastuzumab in metastatic breast cancer patients. J. Transl. Med. 2008, 6:25-35.
9. Billhult A., Lindholm C., Gunnarsson R., Stener-Victorin E. The effect of massage on cellular immunity, endocrine and psychological factors in women with breast cancer: a randomized controlled clinical trial. Auton. Neurosci. 2008, 140(2008):88-95.
10. Blanchard E.B., Andrasik F., Neff D.F., Arena J.G., Ahles T.A., Jurish S.E., Pallmeyer T.P., Saunders N.L., Teders S.J., Barron K.D., Rodichok L.D. Biofeedback and relaxation training with three kinds of headache: treatment effects and their prediction. J. Consult. Clin. Psychol. 1982, 50:562-575.
11. Boon H., Stewart M., Kennard M.A., Gray R., Sawka C., Brown J.B., McWilliam C., Gavin A., Baron R.A., Aaron D., Haines-Kamka T. Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J. Clin. Oncol. 2000, 18:2515-2521.
12. Borkovec T., Nau S. Credibility of analogue therapy rationales. J. Behav. Ther. Exper. Psychiatry 1972, 1:257-260.
13. Canavan T., Doshi N. Cervical cancer. Am. Family Physician 2000, 61:1369-1376.
14. Cella D. Manual for the functional assessment of Cancer Therapy, (FACT) and Functional Assessment of HIV Infection, (FAHI) Measurement System 1994, Rush-Presbyterian St. Lukes Medical Center, Chicago, IL.
15. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., Silberman M., Yellen S.B., Winicour P., Brannon J., Eckberg E., Lloyd S., Purl S., Blendowski C., Goodman M., Barnicle M., Stewart I., McHale M., Bonomi P., Kaplan E., Taylor S., Thomas C.R., Harris J. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J. Clin. Oncol. 1993, 11:570-579.
16. Cheriyan V.T., Krishna S.M., Kumar A., Jayaprakash P.G., Balaram P. Signaling defects and functional impairment in T-cells from cervical cancer patients. Cancer Biother. Radiopharm. 2009, 24:667-673.
17. Cook C.A., Guerrerio J.F., Slater V.E. Healing touch and quality of life in women receiving radiation treatment for cancer: a randomized controlled trial. Alt. Ther. Health Med. 2004, 10:34-41.
18. Curran S.L., Andrykowski M.A., Studts J.L. Short form of the profile of mood states, (POMS-SF): psychometric information. Psychol. Assess. 1995, 7:80-83.
19. Curtis, A.R., Tegeler, C., Burdette, J., Yosipovitch, G., in press. Holistic approach to treatment of intractable central neuropathic itch. J. Am. Acad. Dermatol.
20. Danhauer S.C., Tooze J.A., Holder P., Miller C., Jesse M.T. Healing touch as a supportive intervention for adult acute leukemia patients: a pilot investigation of effects on distress and symptoms. J. Soc. Integr. Oncol. 2008, 6:89-97.
21. Dusek J.A., Otu H.H., Wohlhueter A.L., Bhasin M., Zerbini L.F., Joseph M.G., Benson H., Libermann T.A. Genomic counter-stress changes induced by the relaxation response. PLoS One 2008, 3:e2576.
22. Eifel P.J., Winter K., Morris M., Levenback C., Grigsby P.W., Cooper J., Rotman M., Gershenson D., Mutch D.G. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J. Clin. Oncol. 2004, 22:872-880.
23. Fouladbakhsh J.M., Stommel M., Given B.A., Given C.W. Predictors of use of complementary and alternative therapies among patients with cancer. Oncol. Nurs. Forum 2005, 32:1115-1122.
24. Garcia-Iglesias T., Del Toro-Arreola A., Albarran-Somoza B., Del Toro-Arreola S., Sanchez-Hernandez P.E., Ramirez-Dueñas M.G., Balderas-Peña L.M., Bravo-Cuellar A., Ortiz-Lazareno P.C., Daneri-Navarro A. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 2009, 9:186.
25. Garzetti G., Ciavattini A., Goteri G., Muzzioli M., Mannello B., Romanini C. Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up. Gynecol. Obstet. Invest. 1995, 40:133-138.
26. Hann D., Winter K., Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological studies Depression Scale. J. Psychosom. Res. 1999, 46:437-443.
27. Hernandez-Reif M., Field T., Ironson G., Beutler J., Vera Y. Natural killer cells and lymphocytes increase in women with breast cancer following massage therapy. Int. J. Neurosci. 2005, 115(2005):495-510.
28. Hodgkinson K., Butow P., Fuchs A., Hunt G.E., Stenlake A., Hobbs K.M., Brand A., Wain G. Long-term survival from gynecologic cancer: psychosocial outcomes, supportive care needs and positive outcomes. Gyn. Oncol. 2007, 104:381-389.
29. Jain S., Mills P.J. Biofield therapies: helpful or full of hype? A best evidence synthesis. Int. J. Behav. Med. 2010, 17:1-16.
30. Jhaveri A., Wang Y., McCarthy M.B., Gronowicz G.A. Therapeutic touch affects proliferation and bone formation of human osteoblasts in vitro. J. Orthop. Res. 2008, 26:1541-1546.
31. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 2006, 24:2137-2150.
32. 2+ exchanger and L-type calcium channel. Mol. Cell. Biochem. 2005, 271:51-59.
33. Kiecolt-Glaser J., Glaser R., Wiliger D., Stout J., Messick G., Sheppard S., Ricker D., Romisher S.C., Briner W., Bonnell G. Psychosocial enhancement of immunocompetence in a geriatric population. Health Psychol. 1985, 4:25-41.
34. Luebbert K., Dahme B., Hasenbring M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 2001, 10:490-502.
35. Lutgendorf S., Logan H., Kirchner H., Rothrock N., Svengalis S., Iverson K., Lubaroff D.M. Effects of relaxation and stress on the capsaicin-induced local inflammatory response. Psychosom. Med. 2000, 62:524-534.
36. Lutgendorf S., Sood A.K., Anderson B., McGinn S., Maiseri H., Dao M., Sorosky J., DeGeest K., Ritchie J., Lubaroff D.M. Social support, psychological distress, and natural killer cell activity in ovarian cancer. J. Clin. Oncol. 2005, 23:7105-7113.
37. MacKinnon D.P., Fairchild A.J., Fritz M.S. Mediation analysis. Ann. Rev. Psychol. 2007, 58:593-614.
38. McGregor B., Antoni M., Boyers A., Alferi S., Blomberg B., Carver C. Cognitive-behavioral stress management increases benefit finding and immune function among women with early-stage breast cancer. J. Psychosom. Res. 2004, 56:1-8.
39. Ménard C., Blay J.Y., Borg C., Michiels S., Ghiringhelli F., Robert C., Nonn C., Chaput N., Taïeb J., Delahaye N.F., Flament C., Emile J.F., Le Cesne A., Zitvogel L. Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. Cancer Res. 2009, 69:3563-3569.
40. Mentgen J. Healing touch. Nurs. Clin. North Am. 2002, 36:143-157.
41. Menthe J., Bulbrook M. Healing Touch Level I Notebook (revised ed.) 2002, North Carolina Center for Healing Touch, Carrboro, NC.
42. Molassiotis A., Fernadez-Ortega P., Pud D., Ozden G., Scott J.A., Panteli V., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann. Oncol. 2005, 16:655-663.
43. NCCAM, 2005. Available from: <>http://nccam.nih.gov/health/backgrounds/energymed.htm.
44. NCI, 1999. Common Toxicity Criteria Manual Version 2.0. National Cancer Institute, Washington, DC.
45. Nelson E.L., Wenzel L.B., Osann K., Dogan-Ates S., Chantana N., Reina-Patton A., Laust A.K., Nishimoto K.P., Chicz-DeMet A., duPont N., Monk B.J. Stress, immunity, and cervical cancer: biobehavioral outcomes of a randomized clinical trial. Clin. Cancer Res. 2008, 14:2111-2118.
46. Pillai M., Balaram P., Chidambaram S., Padmanabhan T., Nair M. Development of an immunological staging system to prognosticate disease course in malignant cervical neoplasia. Gyn. Oncol. 1990, 37:200-205.
47. Post-White J., Kinney M.E., Savik K., Berntsen J., Wilcox C., Lerner I. Therapeutic massage and healing touch improve symptoms in cancer. Integr. Cancer Ther. 2003, 2:332-344.
48. Preacher K.J., Hayes A.F. Asymptotic and resampling procedures for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 2008, 40:879-891.
49. Radloff L. The CES-D scale: a self-report depression scale for research in the general population. App. Psychol. Meas. 1977, 1:385-401.
50. Santin A.D., Hermonat P.L., Ravaggi A., Bellone S., Roman J., Pecorelli S., Cannon M., Parham G. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48:997-1006.
51. Satam M., Suraiya J., Nadkarni J. Natural killer and antibody-dependent cellular cytotoxicity in cervical carcinoma patients. Cancer Immunol. Immunother. 1986, 23:56-59.
52. Sheehan T.J., Fifield J., Reisine S., Tennen H. The measurement structure of the Center for Epidemiologic Studies depression scale. J. Pers. Assess. 1995, 64:507-521.
53. Sheeran T.P., Jackson F.R., Dawes P.T., Collins M., Shadforth M.F. Measurement of natural killer cell cytotoxicity by area under a cytotoxic curve. A method suitable for rheumatoid arthritis. J. Immunol. Methods 1988, 115:95-98.
54. Smyth M.J., Cretney E., Kelly J.M., Westwood J.A., Street S.E., Yagita H., Takeda K., van Dommelen S.L., Degli-Esposti M.A., Hayakawa Y. Activation of NK cell cytotoxicity. Mol. Immunol. 2005, 42:501-510.
55. Sparber A., Bauer L., Curt G., Eisenberg D., Levin T., Parks S., Steinberg S.M., Wootton J. Use of complementary medicine by adult patients participating in cancer clinical trials. Oncol. Nurs. Forum 2000, 27:623-630.
56. Tang, R., Tegeler, C., Larrimore, D., Cowgill, S., Kemper, K., in press. Improving the wellbeing of nursing leaders through healing touch training. J. Altern. Complement. Med.
57. Textor S., Dürst M., Jansen L., Accardi R., Tommasino M., Trunk M.J., Porgador A., Watzl C., Gissmann L., Cerwenka A. Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int. J. Cancer 2008, 123:2343-2353.
58. Thornton L.M., Andersen B.L., Crespin T.R., Carson W.E. Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatments. Brain Behav. Immun. 2007, 21:185-194.
59. Thornton L.M., Andersen B.L., Schuler T.A., Carson W.E. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med. 2009, 71:715-724.
60. Vaquer S., Jordá J., López de la Osa E., Alvarez de los Heros J., López-García N., Alvarez de Mon M. Clinical implications of natural killer (NK) cytotoxicity in patients with squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 1990, 36:90-92.
61. Vistad I., Fosså S.D., Dahl A.A. A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer. Gynecol. Oncol. 2006, 102:563-572.
62. Weissman M., Sholomskas D., Pottenger M., Prusoff B., Locke B. Assessing depressive symptoms in five psychiatric populations: a validation study. Am. J. Epidemiol. 1977, 106:203-214.
63. Witek-Janusek L., Albuquerque K., Chroniak K.R., Chroniak C., Durazo-Arvizu R., Mathews H.L. Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer. Brain. Behav. Immun. 2008, 22:969-981.
64. Yan X., Shen H., Jiang H., Zhang C., Hu D., Wang J., Wu X. External Qi of Yan Xin Qigong induces G2/M arrest and apoptosis of androgen-independent prostate cancer cells by inhibiting Akt and NF-kB pathways. Mol. Cell Biochem. 2008, 310:227-234.
65. Yan X., Shen H., Jiang H., Zhang C., Hu D., Wang J., Wu X. External Qi of Yan Xin Qigong differentially regulates the Akt and extracellular signal-regulated kinase pathways and is cytotoxic to cancer cells but not to normal cells. Int. J. Biochem. Cell Biol. 2006, 38:2102-2113.